Deal Announcements

Frontage Laboratories Raises $10 Million Venture Round

Friday, April 25, 2008 5:38:00 AM PDT | VentureDeal Staff

MALVERN, PA -- Pharmaceutical services company Frontage Laboratories, Inc. announced that it has secured new venture capital funding in the amount of $10 million.

Frontage provides pharmaceutical companies with clinical trial support in the areas of GMP synthesis or chemical entities, preclinical studies and bioanalysis and Phase I - IV trial services, among other services.

Baird Capital Partners Asia, Pavilion Capital Partners and others invested in the round.  The company intends to use the funds primarily for sales and marketing expansion.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1